Business Standard

CCMB sets up clinical research facility in Hyderabad

Related News

Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) has set up a (CRF) on its campus in partnership with city-based Nizam's Institute of Medical Sciences (NIMS) to facilitate cell-based research for private players.

director said conducting clinical research was an expensive affair as it required high-end equipment costing Rs 3-4 crore, which most companies could not afford. The CRF would facilitate research and innovation in cell-based therapy including stem cell research.

“Companies will be allowed to do research at CRF. As when they conduct research, they will need intellectual inputs, which CCMB scientists will provide. Three companies from India and abroad have already approached us,” he said.

and CCMB will also use the facility to conduct joint research on how to translate stem cell research into application by taking cells from patients, conducting research and implementing back on the same patients,.

The 40,000-sft laboratory, which was soft-launched three months ago, will be fully operational in the next four months. It has come up with an investment of Rs 26 crore, funded by the Ministry of Science and Technology under the Council of Scientific and Industrial Research.

CCMB to partner ISB
CCMB is planning to partner the Indian School of Business (ISB) to convert its in-house scientific research into commercial ventures.

“The partnership will focus on how to convert scientific innovation into business ventures, where CCMB scientists and PhD scholars will bring their innovation and research and ISB will help in building the business model and bringing venture capitals,” he said.

Scientists in India used to focus on knowledge creation. But, in the last 5-10 years, a new trend has emerged in the country where scientists want to bring their research to the market for the benefits of society. In this regard, CCMB is partnering with business schools.

Read more on:   
|
|
|

Read More

Sebi dismisses matters against Suzlon's two directors

Sebi has dismissed matters that alleged delaying implementation of norms related to insider trading by wind turbine maker Suzlon Energy's two ...

Advertisements

Quick Links

Advertisement

Back to Top